Publications by authors named "I Iu Bychkov"

Background: The gene encodes ATP-dependent RNA helicase SUPV3L1, which is a part of the mitochondrial degradosome complex or SUV3. SUPV3L1 unwinds secondary structures of mitochondrial RNA (mtRNA) and facilitates the degradation of mtRNA molecules. A nonsense homozygous variant in the gene was recently associated with mitochondrial disease.

View Article and Find Full Text PDF

In plants, abscisic acid (ABA) and melatonin (MT) are conventionally treated as molecules mitigating stress responses. To understand the mechanisms of ABA-MT interplay, we examined the effects of ABA and MT treatment in ABA and MT loss-of-function mutants of exposed to high light (HL) stress. ABA constantly suppressed encoding N-acetylserotonin methyltransferase in the context of differential responses of other MT biosynthesis genes in both the wild type (WT) and mutants.

View Article and Find Full Text PDF

Lung cancer is one of the most common types of cancer worldwide. Non-small cell lung cancer (NSCLC), typically caused by and driver mutations, represents the majority of all new lung cancer diagnoses. Overexpression of the RNA-binding protein (RBP) Musashi-2 (MSI2) has been associated with NSCLC progression.

View Article and Find Full Text PDF

Head and neck squamous cell carcinoma (HNSCC) ranks among the most prevalent global cancers. Despite advancements in treatments, the five-year survival rate remains at approximately 66%. The histone methyltransferase NSD1, known for its role in catalyzing histone H3 lysine 36 di-methylation (H3K36me), emerges as a potential oncogenic factor in HNSCC.

View Article and Find Full Text PDF
Article Synopsis
  • Head and neck squamous cell carcinoma (HNSCC) is a prevalent cancer with a 5-year survival rate of about 66%, indicating a need for better treatment options.
  • NSD1, a histone methyltransferase, plays a role in promoting HNSCC growth and its depletion reduces tumor growth while affecting key signaling pathways, particularly Akt/mTORC1.
  • The study reveals that NSD1's absence induces changes in autophagy regulation, suggesting it may serve as a promising therapeutic target for HNSCC treatment.
View Article and Find Full Text PDF